The neuromuscular disease therapeutics market, valued at US$ 11.89 billion in 2023 and US$ 13.70 billion in 2024, is projected to reach US$ 45.62 billion by 2033, growing at a CAGR of ~14.4%. https://finance.yahoo.com/news/neuromuscular-disease-therapeutics-market-reach-152000966.html